Chordoma is an uncommon tumor , so the metastatic cases generally are given more attention. Various cases with central nervous system involvement, cutaneous and mandible metastases have been reported. Metastases to bone is noted in literature but metastases to bilateral clavicle is not reported yet to the best of our knowledge. We hereby present a rare case of sacral chordoma with clavicular metastases. 
Chordoma is a rare ,slow growing neoplasm and known for local recurrence .It has modest propensity for distant metastasis but not an uncommon occurrence. The main metastatic sites are lymph nodes, liver, lung, skin and bones. Here we present a case of primary sacral chordoma with metastases to medial end of both clavicles and systemic spread.
INTRODUCTION CASE STUDY
end of right clavicle of about 8x8cm size with compression of underlying veins and dilated veins in right axilla. Another lesion of 2x2 cm with same characteristics was present at the medial end of left clavicle. Multiple rounded metastatic nodules were present in both lungs and liver. He was considered for palliative radiotherapy to painful region. He received 20 Gy in five fractions by direct anterior field to clavicular region by 6 MV photons. Now he is in regular follow up and is free of pain till date. A 40 years old gentleman presented in October 2005 with progressively increasing swelling in the lower back. On clinical examination there was 6x5 cm, hard ,fixed and nontender swelling in the sacral region. He was investigated and diagnosed as primary sacral chordoma and underwent surgery. He remained asymptomatic for fifteen months. In February 2007, the disease recurred at the same site. The disease was unresectable so was considered for surgical debulking of the tumor followed by adjuvant radiotherapy at another hospital in March 2007. He was asymptomatic for three years when he presented at our insitute on 6.02.2010 with complaint of swelling and pain over right upper chest for last four months and pain in right arm for last fifteen days. On clinical examination at the medial end of right clavicle a 10x8 cm and at the left clavicle 2x2 cm size swelling firm to cystic in consistency, nontender ,fixed to underlying structure, were present ( Figure 1 ). On left scalp region 5x5 cm swelling with similar characteristics was present. Systemic examination was unremarkable. Trucut biopsy from clavicular swelling was done on 06.02.2010 and reported as malignant large cell tumor consistent with metastatic chordoma (Figure 2 ). Mitotic figures were frequent. Large polygonal cells with large pleomorphic nuclei were found. Contrast enhanced CT scan chest was done on 01.02.2010 that revealed expansile destructive involving medial [6] 204
6.3% Sundareson et al [7] 18(vertebral) 36(sacral) 60% 27% Volpe et al 1983 25(spinal) 2% Dahlin et al [4] 59 10% Higinbotham et al [5] 46 48% Histologically there may be some variability, but the major features include a lobular cellular structure, arrangements in cords or clusters, an ample intercellular mucinous matrix, and large physaliphorous cells. Primary treatment for chordomas is wide resection. Metastasis is usually a late event and most often occurs in young patients those with sacrococcygeal or vertebral tumors and those with atypical histological features. Chordomas metastasize in 3 to 48% of the patients harboring these lesions. In literature there is much discrepancy regarding data of metastasis in chordoma. According to Dahlin and MacCarty the 10% incidence of metastasis often cited in literature may be misleading, since many reporters have failed to give reasonable proof that the neoplasms were chordomas. 4 In sharp contrast is the overall 48 percent incidence of distant metastases reported by Higinbotham and coworkers in their 46 cases. 5 Here we are presenting a table regarding data of metastasis from chordoma. (Table 1) In descending order of metastasis, the organs involved by metastasis include the lungs, lymphnodes, liver, bone, skin, muscle, peritoneum, heart, pleura, retroperitoneum, spleen, duramater, kidney and adrenal glands. 6 As chordoma is rare tumor, the metastatic cases generally have DISCUSSION more attention and been given rise to more publications. After reviewing the literature in 1979 chambers et al reported 40 chordoma patients with lung metastasis, 23 with lymphnode, 15 with liver and 12 with bone metastasis. 8 Metastasis to clavicle is well known in carcinomas of thyroid, urinary bladder, breast, kidney,colon and also from malignant pheochromocytoma among others. Bilateral symmetrical metastases to clavicular heads from bronchiogenic carcinoma is also reported. 9 Though metastases to bone is noted in literature but metastasis to clavicle from sacral chordoma is not reported to the best of our knowledge. Here we are presenting data regarding clavicle metastasis from primary sites other than chordoma. (Table 2) In our patient, primary site was sacrum. Radiographic findings were expansile lytic lesion with soft tissue mass although intratumoral calcification was not present. Histologically a lobular cellular structure with arrangements in cords with ample intercellular mucinous matrix was present. Risk factors for metastasis included younger age group (40 years of age) and the location of tumor (sacral region). Radiation therapy offers excellent palliation of pain in bone metastases and improves quality of life. Our patient had 90% subjective relief in pain. The overall median survival time with chordoma has been estimated to be approximately 6 years, with a survival rate of 70% at 5 years, falling to 40% at 10 years. Our patient presented with bone, lung and liver metastasis and the metastasis developed after five years of diagnosis. Metastatic disease is considered of adverse prognostic significance because most of the patients die within 40 months.
